Skip to main content

Therapeutic cloning to become a reality for Britain

The potential therapeutic benefits of research on human embryos areenormous and outweigh the ethical and safety concerns, the UKgovernment decided this week.

Written byJoanna Lyford
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

LONDON, August 18. A mixture of horror and excitement greeted the British government's decision this week to allow stem cell research and therapeutic cloning. For most scientists, the risk–benefit balance is clearly weighted in favour of such research, and the decision heralds a new era of therapeutic possibilities. But for many people in Britain it smacks of eugenics and meddling with the sanctity of life. So what is all the fuss about?

On Wednesday Tony Blair's government endorsed the conclusions of an expert committee led by Liam Donaldson, the chief medical officer, that embryonic stem cells — primordial cells that can differentiate into any mature cell type given the right conditions — have "enormous potential" to create new forms of treatment for currently incurable diseases. At present, research on human embryos up to 14 days old is permitted for a handful of specific purposes related to infertility. Animal studies, mainly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays